ATE301474T1 - Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten - Google Patents
Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthaltenInfo
- Publication number
- ATE301474T1 ATE301474T1 AT01952176T AT01952176T ATE301474T1 AT E301474 T1 ATE301474 T1 AT E301474T1 AT 01952176 T AT01952176 T AT 01952176T AT 01952176 T AT01952176 T AT 01952176T AT E301474 T1 ATE301474 T1 AT E301474T1
- Authority
- AT
- Austria
- Prior art keywords
- bactrial
- sulbactam
- ampicillin
- compositions
- treating
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 title 1
- 229960000723 ampicillin Drugs 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 title 1
- 229960005256 sulbactam Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21541800P | 2000-06-30 | 2000-06-30 | |
| US23277300P | 2000-09-15 | 2000-09-15 | |
| US27930601P | 2001-03-28 | 2001-03-28 | |
| PCT/US2001/019712 WO2002002095A2 (en) | 2000-06-30 | 2001-06-21 | Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301474T1 true ATE301474T1 (de) | 2005-08-15 |
Family
ID=27396119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01952176T ATE301474T1 (de) | 2000-06-30 | 2001-06-21 | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6544991B2 (de) |
| EP (1) | EP1301207B1 (de) |
| JP (1) | JP2004501965A (de) |
| AR (1) | AR029544A1 (de) |
| AT (1) | ATE301474T1 (de) |
| AU (1) | AU2001272961A1 (de) |
| DE (1) | DE60112581T2 (de) |
| DK (1) | DK1301207T3 (de) |
| ES (1) | ES2245698T3 (de) |
| MY (1) | MY128739A (de) |
| PE (1) | PE20020295A1 (de) |
| PT (1) | PT1301207E (de) |
| TW (1) | TWI265030B (de) |
| WO (1) | WO2002002095A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
| BR0308806A (pt) * | 2002-03-29 | 2005-01-04 | Upjohn Co | Uso de oxazolidinonas para tratar infecções do tipo pé diabético |
| WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
| KR20080005599A (ko) * | 2005-05-06 | 2008-01-14 | 와이어쓰 | 헤파린 존재하에 티게사이클린의 전달 |
| WO2007000644A1 (en) | 2005-06-29 | 2007-01-04 | Pharmacia & Upjohn Company Llc | Homomorpholine oxazolidinones as antibacterial agents |
| WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
| WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
| WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
| WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
| WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
| EP2367820B1 (de) | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Neue antimikrobielle substanzen |
| BR112012000657A2 (pt) | 2009-06-26 | 2016-11-16 | Panacea Biotec Ltd | novos azabicilohexanos |
| WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| WO2021184339A1 (en) | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
| US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
| BE641785A (de) | 1962-12-26 | |||
| US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| DE4425612A1 (de) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| RU2175324C2 (ru) | 1995-09-01 | 2001-10-27 | Фармация Энд Апджон Компани | Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами |
| DE19601264A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19601265A1 (de) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| ES2166073T3 (es) | 1996-04-11 | 2002-04-01 | Upjohn Co | Procedimiento para preparar oxazolidinonas. |
| DK1028940T3 (da) | 1997-11-07 | 2007-07-30 | Pharmacia & Upjohn Co Llc | Fremgangsmåde til fremstilling af oxazolidinoner |
| EP1149089B1 (de) | 1999-02-01 | 2003-03-26 | PHARMACIA & UPJOHN COMPANY | VERFAHREN ZU HERSTELLUNG VON o-FLUORIERTEN TETRAHYDROTHIOPYRAN CARBAMATEN |
-
2001
- 2001-06-21 ES ES01952176T patent/ES2245698T3/es not_active Expired - Lifetime
- 2001-06-21 PT PT01952176T patent/PT1301207E/pt unknown
- 2001-06-21 EP EP01952176A patent/EP1301207B1/de not_active Expired - Lifetime
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en not_active Ceased
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/ja active Pending
- 2001-06-21 DE DE60112581T patent/DE60112581T2/de not_active Expired - Fee Related
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 DK DK01952176T patent/DK1301207T3/da active
- 2001-06-21 AT AT01952176T patent/ATE301474T1/de not_active IP Right Cessation
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/es not_active Application Discontinuation
- 2001-06-29 TW TW090115958A patent/TWI265030B/zh not_active IP Right Cessation
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
- 2001-06-29 AR ARP010103125A patent/AR029544A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004501965A (ja) | 2004-01-22 |
| WO2002002095A3 (en) | 2003-02-06 |
| DE60112581T2 (de) | 2006-06-01 |
| US20020022610A1 (en) | 2002-02-21 |
| DE60112581D1 (de) | 2005-09-15 |
| EP1301207B1 (de) | 2005-08-10 |
| WO2002002095B1 (en) | 2004-03-25 |
| PE20020295A1 (es) | 2002-04-07 |
| EP1301207A2 (de) | 2003-04-16 |
| TWI265030B (en) | 2006-11-01 |
| ES2245698T3 (es) | 2006-01-16 |
| AU2001272961A1 (en) | 2002-01-14 |
| WO2002002095A2 (en) | 2002-01-10 |
| MY128739A (en) | 2007-02-28 |
| PT1301207E (pt) | 2005-11-30 |
| DK1301207T3 (da) | 2005-10-10 |
| US6544991B2 (en) | 2003-04-08 |
| AR029544A1 (es) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE301474T1 (de) | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten | |
| ATE547101T1 (de) | Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten | |
| DE602004017037D1 (de) | 2,3-dihydro-6-nitroimidazoä2,1-büoxazolverbindungen zur behandlung von tuberkulose | |
| DE60138129D1 (de) | Apparat zur behandlung von zähnen | |
| DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
| ATE494884T1 (de) | Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| DE60011570D1 (de) | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen | |
| NL1026892A1 (nl) | ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie. | |
| EP1408945A4 (de) | Verfahren, verbindungen und zusammensetzungen zur reduzierung von körperfett und zur modulierung des fettsäurestoffwechsels | |
| ATE318138T1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| EP1626730A4 (de) | Verfahren, gerät und zusammensetzung zur behandlung von akne | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60117977D1 (de) | Vorrichtungen zur behandlung von harninkontinenz | |
| DE60228749D1 (de) | Cephalosporin verbindungen enthaltende zusammensetzungen und deren verwendung zur behandlung von bakteriellen infektionen bei hunden und katzen | |
| NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
| ZA200101821B (en) | Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection. | |
| PT1282616E (pt) | Derivados de hidroxifenil-piperidin-4-ilideno-metil-benzamida para o tratamentoda dor | |
| DE60208186D1 (de) | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen | |
| DE60218451D1 (de) | 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation | |
| DE60221670D1 (de) | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen | |
| DE60114439D1 (de) | Verfahren zur antimikrobiellen behandlung von fasermaterialien | |
| ATE493145T1 (de) | Methode zur behandlung von staphylokokkeninfektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1301207 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |